Renal disease News and Research

RSS

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Alexion Pharmaceuticals, Inc. today announced the presentation of research that provides further insight into the clinical consequences of paroxysmal nocturnal hemoglobinuria (PNH), and positive impact of Soliris® (eculizumab) therapy on long-term outcomes.

13 Jun 2011

HHS adds eight substances to 12th Report on Carcinogens

The U.S. Department of Health and Human Services added eight substances to its Report on Carcinogens, a science-based document that identifies chemicals and biological agents that may put people at increased risk for cancer.

13 Jun 2011

Viewpoints: Health law's latest day in court; Obama's "abdication" on Medicare; Blue Shield profits vs. premiums

Provisions of the federal Affordable Care Act, also known as ObamaCare, "may violate the constitution of Ayn Rand, but they do not violate the Constitution of the United States," acting solicitor general Neal Kumar Katyal told a three-judge panel of the 11th Circuit Court of Appeals Wednesday. Conversely, attorney Paul Clement, representing Georgia and 25 other states, framed the issue of mandated purchase of health insurance as an issue of liberty.

10 Jun 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

DaVita completes nationwide rollout of wireless Internet access at dialysis treatment clinics

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, today announced that every one of its clinics across the country now makes wireless Internet access available to all patients while they undergo dialysis treatments.

4 May 2011

Fresenius Medical Care first quarter net revenue increases 5% to $3,036 million

Fresenius Medical Care, the world's largest provider of dialysis products and services, today announced its results for the first quarter of 2011.

4 May 2011

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, in end-stage renal disease patients receiving hemodialysis.

4 May 2011

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

Declining rates of hospitalization have discouraged primary care doctors from seeing their patients in the hospital and encouraged the growing use of "hospitalists," a new physician specialty focused on the care of hospitalized patients.

30 Apr 2011

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.

30 Apr 2011

DVA is now DaVita Labs

Operating as a division of DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, DVA Laboratory Services announced its new company name, DaVita Labs.

30 Apr 2011

Ramipril can effectively reduce risk of ESRD in obese patients

The angiotensin-converting enzyme inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

29 Apr 2011

PVT1 gene may help reduce diabetic nephropathy

A gene called PVT1 may help reduce the kidneys ability to filter blood, leading to kidney disease, kidney failure and death, according to a study published today by researchers at the Translational Genomics Research Institute.

25 Apr 2011

DaVita re-designs its leading online kidney disease resource

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease and chronic kidney disease, today announced the redesign and launch of DaVita.com, the leading online resource for information about kidney disease.

19 Apr 2011

Japan Tobacco and Torii commence ferric citrate Phase 3 clinical program for hyperphosphatemia

Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. (JT) and Torii Pharmaceutical Co., Ltd., JT's pharmaceutical business subsidiary, has commenced the Phase 3 clinical program of ferric citrate in Japan for the treatment of patients with hyperphosphatemia.

18 Apr 2011

Klotho hormone can protect kidney from renal fibrosis

A natural hormone known to inhibit aging can also protect kidneys against renal fibrosis, UT Southwestern Medical Center researchers have demonstrated.

15 Apr 2011

KCP commends CMS for eliminating 'transition adjustment' imposed on new ESRD PPS

Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease prospective payment system.

2 Apr 2011

New CMS reimbursement system for ESRD may place cost constraints on clinics

According to Millennium Research Group, the global authority on medical technology market intelligence, the new reimbursement system from the Centers for Medicare & Medicaid Services for end stage renal disease will have a mixed but mostly negative effect on the market for ESRD treatment devices.

1 Apr 2011

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

Interventional radiologists have completed the first human randomized controlled trial of therapeutic renal denervation or RDN—a procedure that uses a catheter-based probe inserted into the renal artery that emits high-frequency energy to deactivate the nerves near the kidneys that are linked to high blood pressure.

29 Mar 2011

Lupus nephritis ESRD study finds increase in incidence rates among children, African Americans

New research documenting changes in the incidence and outcomes of end-stage renal disease in the U.S. between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans.

28 Mar 2011

Renal disease News and Research

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

HHS adds eight substances to 12th Report on Carcinogens

Viewpoints: Health law's latest day in court; Obama's "abdication" on Medicare; Blue Shield profits vs. premiums

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

DaVita completes nationwide rollout of wireless Internet access at dialysis treatment clinics

Fresenius Medical Care first quarter net revenue increases 5% to $3,036 million

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

DVA is now DaVita Labs

Ramipril can effectively reduce risk of ESRD in obese patients

PVT1 gene may help reduce diabetic nephropathy

DaVita re-designs its leading online kidney disease resource

Japan Tobacco and Torii commence ferric citrate Phase 3 clinical program for hyperphosphatemia

Klotho hormone can protect kidney from renal fibrosis

KCP commends CMS for eliminating 'transition adjustment' imposed on new ESRD PPS

New CMS reimbursement system for ESRD may place cost constraints on clinics

Interventional radiologists complete RDN human trial in patients with uncontrolled hypertension

Lupus nephritis ESRD study finds increase in incidence rates among children, African Americans

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News